» Articles » PMID: 28220196

The Associations Between Serum 25-hydroxyvitamin D Level and the Risk of Total Fracture and Hip Fracture

Overview
Journal Osteoporos Int
Date 2017 Feb 22
PMID 28220196
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Data on the association between serum 25(OH) vitamin D level and the risk of fractures are conflicting. This study aimed to provide a summary of prospective cohort or nested case-control studies on the association between serum 25(OH) vitamin D level and the risk of total fractures and hip fractures.

Methods: We identified relevant studies by searching the PubMed, EMBASE, and OVID databases from their inception to June 1, 2016. We included published prospective cohort or nested case-control studies evaluating the associations of serum 25(OH) vitamin D level with the fracture risk. Two reviewers abstracted the data independently. Relative risks (RRs) with 95% confidence intervals (CIs) were derived throughout the whole analysis.

Results: Sixteen prospective cohort studies and three nested case-control studies were included. We found that low serum 25(OH) vitamin D level was significantly associated with the risk of total fractures (RR 1.25, 95% CI 1.06-1.43; I  = 31.3%, p for heterogeneity = 0.15) and hip fractures (RR 1.48, 95% CI 1.29-1.68; I  = 0%, p for heterogeneity = 0.51). The hip fracture risk was increased by 40% for each SD decrease in serum 25(OH) vitamin D level (RR 1.40, 95% CI 1.20-1.61; I  = 0%, p for heterogeneity = 0.51). The per SD decrease in serum 25(OH) vitamin D level was not associated with the increased risk of total fractures (RR 1.14, 95% CI 0.93-1.35; I  = 63.2%, p for heterogeneity = 0.04).

Conclusions: Our study suggests that low serum 25(OH) vitamin D level is associated with increased risks of total and hip fractures. In the analyzed studies, the per SD decrease in serum 25(OH) vitamin D level was associated with the hip fracture risk but not with the total fracture risk.

Citing Articles

Evaluating agreement between individual nutrition randomised controlled trials and cohort studies - a meta-epidemiological study.

Stadelmaier J, Bantle G, Gorenflo L, Kiesswetter E, Nikolakopoulou A, Schwingshackl L BMC Med. 2025; 23(1):36.

PMID: 39838444 PMC: 11752614. DOI: 10.1186/s12916-025-03860-2.


Vitamin D and/or calcium to prevent fractures and falls: protocol for a systematic review and meta-analysis.

Masse O, Mercurio C, Dupuis S, Arruda A, Desforges K, Dugre N BMJ Open. 2024; 14(12):e085902.

PMID: 39672580 PMC: 11647347. DOI: 10.1136/bmjopen-2024-085902.


Vitamin D Deficiency Does Not Affect Cognition and Neurogenesis in Adult C57Bl/6 Mice.

Doumit M, El-Mallah C, El-Makkawi A, Obeid O, Kobeissy F, Darwish H Nutrients. 2024; 16(17).

PMID: 39275253 PMC: 11396937. DOI: 10.3390/nu16172938.


Nutrition, Vitamin D, and Calcium in Elderly Patients before and after a Hip Fracture and Their Impact on the Musculoskeletal System: A Narrative Review.

Cianferotti L, Bifolco G, Caffarelli C, Mazziotti G, Migliaccio S, Napoli N Nutrients. 2024; 16(11).

PMID: 38892706 PMC: 11174536. DOI: 10.3390/nu16111773.


Selective estrogen receptor modulators (SERMs) with vitamin D composite agent can prevent fracture better than SERMs treatment: based on the National Health Claims Database 2017-2019.

Byun S, Kim H, Lee S, Kim S Osteoporos Int. 2024; 35(5):775-783.

PMID: 38240755 DOI: 10.1007/s00198-024-07022-7.


References
1.
Zhang X, Yu Z, Yu M, Qu X . Alcohol consumption and hip fracture risk. Osteoporos Int. 2014; 26(2):531-42. DOI: 10.1007/s00198-014-2879-y. View

2.
Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H . Meta-analysis: serum vitamin D and breast cancer risk. Eur J Cancer. 2010; 46(12):2196-205. DOI: 10.1016/j.ejca.2010.03.037. View

3.
Holick M . High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc. 2006; 81(3):353-73. DOI: 10.4065/81.3.353. View

4.
Azali P, Barbasso Helmers S, Kockum I, Olsson T, Alfredsson L, Charles P . Low serum levels of vitamin D in idiopathic inflammatory myopathies. Ann Rheum Dis. 2012; 72(4):512-6. DOI: 10.1136/annrheumdis-2012-201849. View

5.
Higgins J, Thompson S . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-58. DOI: 10.1002/sim.1186. View